Our recent publication has further suggested a potential clinical application of utilizing reciprocal miR-99b-5p/mTOR (down/up) pairing as a diagnostic/prognostic biomarker in AA PCa [15]. This evidence concerns the gene MTOR and posterior cortical atrophy.